Endometrial malignancies arising on endometrial polyps and precursor lesions

Introduction: Polyps are covered with endometrial epithelium and composed of varying proportions of gland, stroma, and blood vessels. Traditionally, endometrial polyps are accepted as a precursor of cancer. The aim of this study was to evaluate the relationship between malignancies arising on endometrial polyps and precursor lesions of these malignancies. Materials and Methods: Data of patients who underwent total abdominal hysterectomy because of a malignancy diagnosed on endometrial polyps were obtained retrospectively from pathology archives. Results: When all malignancies on endometrial polyp were considered, 37% of cases were Type I, 55% were Type II, and 7% were carcinosarcoma. Endometrial intraepithelial carcinoma (EIC) was detected as tumor-adjacent areas on the polyp in eight of the patients who were diagnosed with serous carcinoma. Conclusion: The authors found a precursor lesion in 20 (74%) of their patients who showed endometrial malignancy developing on endometrial polyps. Even when an overt malignancy is not detected on polyps in the curettage material, precursor lesions should be carefully searched.

Polyp; Endometrial hyperplasia; Endometrial disease; Adenocarcinoma; Endometrioid.

[1] Baiocchi G., Manci N., Pazzaglia M., Giannone L., Burnelli L., Giannone E., et al.: “Malignancy in endometrial polyps: a 12-year experience”. Am. J. Obstet. Gynecol., 2009, 201, 642.e1.

[2] Widrich T., Bradley L., Mitchinson A., Collins R.: “Comparison of saline infused sonography with office hysterescopy for the evaluation of the endometrium”. Am. J. Obstet. Gynecol., 1996, 174, 1327.

[3] Sherman M.E., Mazur M.T., Kurman R.J.: “Benign diseases of the endometrium”. In: Kurman R.J. (ed). Blaunstein’s pathology of the female genital tract. 3rded. New York, NY: Springer, 2002, 421.

[4] Caspi B., Appelman Z., Goldchmit R., Ashkenazi M., Haruvy Y., Hagay Z.: “The bright edge of the endometrial polyp”. Ultrasound Obstet. Gynecol., 2000, 15, 327.

[5] Clevenger-Hoeft M., Syrop C.H., Stovall D.W., Van Voorhis B.J.: “Sonoghysterography in premenopousal women with and without abnormal bleeding”. Obstet. Gynecol., 1999, 94, 516.

[6] DeWaay D.J., Syrop C.H., Nygaard I.E., Davis W.A., Van Voorhis B.J.: “Natural history of uterine polyps and leiomyomata”. Obstet. Gynecol., 2002, 100, 3.

[7] Goldstein S.R., Monteagudo A., Popiolek D., Mayberry P., Timor- Tritsch I.: “Evaluation of endometrial polyps”. Am. J. Obstet. Gynecol., 2002, 186, 669.

[8] Perri T., Rahimi K., Ramanakumar A.V., Wou K., Pilavdzic D., Franco E.L., et al.: “Are endometrial polyps true cancer precursors?” Am. J. Obstet. Gynecol., 2010, 203, 232.e1.

[9] Schlaen I., Bergeron C., Ferenczy A., Wong P., Naves A.: “Endometrial polyps: a study of 204 cases”. Surg. Pathol., 1988, 375, 382.

[10] Sant’Ana de Almeida E.C., Nogueira A.A., Candido dos Reis F.J., Zambelli Ramalho L.N., Zucoloto S.: “Immunohistochemical expression of estrogen and progesterone receptors in endometrialpolyps and adjacent endometrium in postmenopausal women”. M aturitas, 2004, 49, 229.

[11] Cheng W.F., Lin H.H., Torng P.L., Huang S.C.: “Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients”. Gynecol. Oncol., 1997, 66, 233.

[12] Carlson J.W., Mutter G.L.: “Endometrial intraepithelial neoplasia is associated with polyps and frequently has metaplastic change”. Histopathology, 2008, 53, 325.

[13] Hileeto D., Fadare O., Martel M., Zheng W.: “Age dependent association of endometrial polyps with increased risk of cancer involvement”.World J. Surg. Oncol., 2005, 3, 8.

[14] Ben-Arie B., Goldshmit C., Laviv Y., Levy R., Caspi B., Huszar M., et al.: “The malignant potential of endometrial polyps”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2004, 115, 206.

[15] Martin-Ondarza C., Gil-Moreno A., Torres-Cuesta L., García A.,Eyzaguirre F., Díaz-Feijoo B., Xercavins J.: “Endometrial cancer in polyps: a clinical study of 27 cases”. Eur. J. Gynaecol. Oncol., 2005, 26, 55.

[16] Mossa B., Torcia F., Avenoso F., Tucci S., Marziani R.: “Occurrence of malignancy in endometrial polyps during postmenopause”. Eur. J. Gynaecol. Oncol., 2010, 31, 165.

[17] Giordano G., Gnetti L., Merisio C., Melpignano M.: “Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps”. Maturitas, 2007, 20, 190.

[18] McCluggage W.G., Sumathi V.P., McManus D.T.: “Uterine serouscarcinoma and endometrial intraepithelial carcinoma arising in endometrialpolyps: report of 5 cases, including 2 associated with tamoxifen therapy”. Hum. Pathol., 2003, 34, 93 9.

[19] Hui P, Kelly M., O’Malley D.M., Tavassoli F., Schwartz P.E.: “Minimal uterine serous carcinoma: a clinicopathological study of 40 cases”. Mod. Pathol., 2005, 18, 75.

[20] Carcangiu M.L., Yan L.K., Chambers J.T.: “Stage IA uterine serous carcinoma. A study of 13 cases”. Am. J. Surg. Pathol., 1997, 21, 1507.

[21] Chang-Halpenny C.H., Natarajan S., Hwang-Graziano J.: “Early stage papillary serous or clear cell carcinoma confined to or involving an endometrial polyp: outcomes with and without adjuvant therapy”. Gynecol. Oncol., 2013, 131, 598.

[22] Wheeler D.T., Bell K.A., Kurman R.J., Sherman M.E.: “Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation”. Am. J. Surg. Pathol., 2000, 26, 797.

[23] Jordan L.B., Abdul-Kader M., Al-Nafussi A.: “Uterine serous papillary carcinoma: histopathologic changes within the female genital tract”. Int. J. Gynecol. Cancer, 2001, 1, 283.

[24] Spiegel G.W.: “Endometrial carcinoma in situ in post-menopausal women”. Am. J. Surg. Pathol., 1995, 19, 417.

[25] Soslow R.A., Pirog E., Isacson C.: “Endometrial intraepithelial carcinoma with associated peritoneal carcinomatosis”. Am J. Surg. Pathol., 2000, 24, 726.

[26] Chiesa-Vottero A.G., Malpica A., Deavers M.T., Broaddus R., Nuovo G.J., Silva E.G.: “Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma”. Int. J. Gynecol. Pathol., 2007, 26, 328.

[27] Trahan S., Tetu B., Raymond P.E.: “Serous papillary carcinoma of the endometrium arising from endometrial polyps: a clinical, histological and immunohistochemical study of 13 cases”. Hum. Pathol., 2005, 36, 1316.

[28] Yemelyanova A., Ji H., Shih leM., Wang T.L., Wu L.S., Ronnett B.M.: “Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases”. Am. J. Surg. Pathol., 2009, 33, 1504.

[29] Alkushi A., Clarke B.A., Akbari M., Makretsov N., Lim P., Miller D., et al.: “Identification of prognostically relevant and reproducible subsets of endometrial adenocarcinoma based on clustering analysis of immunostaining data”. Mod. Pathol., 2007, 20, 1156.

[30] Nofech-Mozes S., Khalifa M.A., Ismiil N., Saad R.S., Hanna W.M., Covens A., Ghorab Z.: “Immunophenotyping of serous carcinomaof the female genital tract”. Mod. Pathol., 2008, 21, 1147.

[31] Clement P.B., Young R.H.: “Non-endometrioid carcinomas of the uterine corpus: a review of their pathology with emphasis on recentadvances and problematic aspects”. Adv. Anat. Pathol., 2004, 11, 117.

[32] Webb G.A., Lagios M.D.: “Clear cell carcinoma of the endometrium”. Am. J. Obstet. Gynecol., 1987, 156, 1486.

[33] Malpica A., Tornos C., Burke T.W., Silva E.G.: “Low-stage clearcell carcinoma of hte endometrium”. Am. J. Surg. Pathol., 1995, 19, 769.

[34] Fadare O., Liang S.X., Ulukus E.C., Chambers S.K., Zheng W.: “Precursors of endometrial clear cell carcinoma”. Am. J. Surg. Pathol., 2006, 30, 1519.

[35] Abeler V.M., Vergote I.B., Kjorstad K.E., Tropé C.G.: “Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern”. Cancer, 1996, 78, 1740.

[36] Posligua L., Malpica A., Liu J., Brown J., Deavers M.T.: “Combined large cell neuroendocrine carcinoma and papillary serous carcinoma of the endometrium eith pagetoid spread”. Arch. Pathol. Lab. Med., 2008, 132, 1821.